People · Operator
Named in public records as an officer, director or promoter · active 2013–2013 · Business Services, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Core2 Group Inc. | — | Business Services | Series A | $9.6M | $107.9M | 2013 |
| Mobius Therapeutics LLC | — | Pharmaceuticals | Series A | $7.4M | $154.9M | 2013 |
| Dolor Technologies LLC | — | Pharmaceuticals | Pre-Seed | $800K | $37.8M | 2013 |
Mark J. Wright at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mark J. Wright on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Mark Wright | 1 | 6 |
| Thomas E. Dailey | 1 | 2 |
| Andrew J. Parsons | 1 | 2 |
| Ed Timm | 1 | 1 |
| Joseph J Duda | 1 | 1 |
| Dendy J Young | 1 | 1 |
| Jack J Wyant | 1 | 1 |
| Robert J Mark | 1 | 1 |
| William J. Pipkin | 1 | 1 |
| Corey J. Ericksen | 1 | 1 |
| D.J. J. Poyfair | 1 | 1 |
| Michael J. Marcum | 1 | 1 |
| Edward J. Timm | 1 | 1 |
| Richard J. Farnsworth | 1 | 1 |
| James J. Anderson | 1 | 1 |
| Dean J. Vandekamp | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.